Innovis Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Innovis Asset Management's TMO Position: Q3 2023 in Review
Innovis Asset Management increased its Thermo Fisher Scientific (TMO) stake by 12% in Q3 2023, buying an estimated $724K and bringing the position to 12,366 shares worth $6.26M. The position accounts for 2.41% of the portfolio, ranked #16.
Innovis Asset Management first reported a position in TMO in Q4 2022 and has held it in 4 quarters since. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Innovis Asset Management held 12,366 shares of Thermo Fisher Scientific worth $6.26M as of Q3 2023.
- Innovis Asset Management bought 1,358 Thermo Fisher Scientific shares in Q3 2023, an estimated $724K.
- Thermo Fisher Scientific made up 2.41% of Innovis Asset Management's portfolio in Q3 2023, its #16 holding.
- Innovis Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 4 quarters since.
- 2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.